In Asia, the rate of 30 bp deletion mutations of the LMP1-EBV gene in NPC patients accounted for the highest rate (79%), followed by that in the Americas (64%) and Europe, with north Africa having the lowest rate (59%). The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.